Ratio of S-adenosylmethionine to S-adenosylhomocysteine as a sensitive indicator of atherosclerosis

Molecular Medicine Reports

Volumn 14, Issue 1, 2016, Pages 289-300

  Zhang, Huiping ^a   Liu, Zhihong ^a,b   Ma, Shengchao ^a,c   Zhang, Hui ^a   Kong, Fanqi ^a   He, Yangyang ^a   Yang, Xiaoling ^a   Wang, Yanhua ^a   Xu, Hua ^a   Yang, Anning ^a   Tian, Jue ^a   Zhang, Minghao ^a   Cao, Jun ^a   Jiang, Yideng ^a   Guo, Xiong ^b  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; DNA methylation; Homocysteine; S adenosylmethionine S adenosylhomocysteine ratio

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; EXTRACELLULAR SUPEROXIDE DISMUTASE; FATTY ACID BINDING PROTEIN 4; FOLIC ACID; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; APOLIPOPROTEIN E; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; SOD3 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DNA METHYLATION; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; ANIMAL; BLOOD; DEFICIENCY; DISEASE MODEL; GENETICS; INTERSPERSED REPEAT; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOMARKERS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DNA METHYLATION; FATTY ACID-BINDING PROTEINS; HOMOCYSTEINE; INTERSPERSED REPETITIVE SEQUENCES; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; SUPEROXIDE DISMUTASE;

EID: 84973442707     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5230     Document Type: Article

References (53)

1. Segers D, Lipton JA, Leenen PJ, Cheng C, Tempel D, Pasterkamp G, Moll FL, de Crom R and Krams R: Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans. Int J Inflam 2011: 936109, 2011.
2. Orbay H, Hong H, Zhang Y and Cai W: Positron emission tomography imaging of atherosclerosis. Theranostics 3: 894-902, 2013.
3. Ma S, Zhang H, Sun W, Gong H, Wang Y, Ma C, Wang J, Cao C, Yang X, Tian J and Jiang Y: Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE-/-mice. Acta Biochim Biophys Sin (Shanghai) 45: 391-400, 2013.
4. Green TJ, Skeaff CM, McMahon JA, Venn BJ, Williams SM, Devlin AM and Innis SM: Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations. Br J Nutr 103: 1629-1634, 2010.
5. Pizzolo F, Blom HJ, Choi SW, Girelli D, Guarini P, Martinelli N, Stanzial AM, Corrocher R, Olivieri O and Friso S: Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. J Am Coll Nutr 30: 11-18, 2011.
6. Ma SL, Tang NL and Lam LC: Association of gene expression and methylation of UQCRC1 to the predisposition of Alzheimer's disease in a Chinese population. J Psychiatr Res 76: 143-147, 2016.
7. Sipkens JA, Hahn NE, Blom HJ, Lougheed SM, Stehouwer CD, Rauwerda JA, Krijnen PA, van Hinsbergh VW and Niessen HW: S-Adenosylhomocysteine induces apoptosis and phosphatidylserine exposure in endothelial cells independent of homocysteine. Atherosclerosis 221: 48-54, 2012.
8. Tehlivets O: Homocysteine as a risk factor for atherosclerosis: Is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism? J Lipids 2011: 702853, 2011.
9. Kerins DM, Koury MJ, Capdevila A, Rana S and Wagner C: Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 74: 723-729, 2001.
10. Loehrer FM, Schwab R, Angst CP, Haefeli WE and Fowler B: Influence of oral S-adenosyl-methionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humans. J Pharmacol Exp Ther 282: 845-850, 1997.
11. Loehrer FM, Haefeli WE, Angst CP, Browne G, Frick G and Fowler B: Effect of methionine loading on 5-methyltetrahydrofolate, 5-adenosyl-methionine and S-adenosylhomocysteine in plasma of healthy humans. Clin Sci 91: 79-86, 1996.
12. Loehrer FM, Angst CP, Brunner FP, Haefeli WE and Fowler B: Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: A cause for disturbed methylation reactions? Nephrol Dial Transplant 13: 656-661, 1998.
13. Meehan RR and Stancheva I: DNA methylation and control of gene expression in vertebrate development. Essays Biochem 37: 59-70, 2001.
14. Chen NC, Yang F, Capecci LM, Gu Z, Schafer AI, Durante W, Yang XF and Wang H: Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J 24: 2804-2817, 2010.
15. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002.
16. Fukushige S and Horii A: DNA methylation in cancer: A gene silencing mechanism and the clinical potential of its biomarkers. Tohoku J Exp Med 229: 173-185, 2013.
17. Lakshmi SV, Naushad SM, Reddy CA, Saumya K, Rao DS, Kotamraju S and Kutala VK: Oxidative stress in coronary artery disease: Epigenetic perspective. Mol Cell Biochem 374: 203-211, 2013.
18. Liu ZH, Chen LL, Deng XL, Song HJ, Liao YF, Zeng TS, Zheng J and Li HQ: Methylation status of CpG sites in the MCP-1 promoter is correlated to serum MCP-1 in Type 2 diabetes. J Endocrinol Invest 35: 585-589, 2012.
19. Jiang Y, Zhang H, Sun T, Wang J, Sun W, Gong H, Yang B, Shi Y and Wei J: The comprehensive effects of hyperlipidemia and hyperhomocy-steinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/-mice. Acta Biochim Biophys Sin (Shanghai) 44: 866-875, 2012.
20. Zulli A, Widdop RE, Hare DL, Buxton BF and Black MJ: High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler Thromb Vasc Biol 23: 1358-1363, 2003.
21. Jiang Y, Sun T, Xiong J, Cao J, Li G and Wang S: Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim Biophys Sin (Shanghai) 39: 657-667, 2007.
22. Hagebeuk EE, Duran M, Abeling NG, Vyth A and Poll-The BT: S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation. J Inherit Metab Dis 36: 967-972, 2013.
23. Agardh HE, Gertow K, Salvado DM, Hermansson A, van Puijvelde GH, Hansson GK, N-Berne GP and Gabrielsen A: Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice. J Cell Mol Med 17: 303-310, 2013.
24. Maksimenko AV and Vavaev AV: Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: The next stage of pharmacological counterwork to the oxidative stress. Heart Int 7: e3, 2012.
25. Linic IS, Sosa I, Kovacevic M, Ivancic A, Trobonjaca Z, Ledic D, Grubesic A, Dvornik S and Stifter S: Predicting carotid restenosis by comparison of plaque MCP-1 mRNA expression and serum levels. Med Hypotheses 80: 26-28, 2013.
26. Ikkruthi S, Rajappa M, Nandeesha H, Satheesh S, Sundar I, Ananthanarayanan PH and Harichandrakumar KT: Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese south indian men: An indication for increased cardiovascular risk. Acta Physiol Hung 101: 13-20, 2014.
27. Ajith TA and Ranimenon: Homocysteine in ocular diseases. Clin Chim Acta 450: 316-321, 2015.
28. Wang Y, Chen S, Yao T, Li D, Wang Y, Li Y, Wu S and Cai J: Homocysteine as a risk factor for hypertension: A 2-year follow-up study. PLoS One 9: e108223, 2014.
29. Zhang D, Wen X, Wu W, Xu E, Zhang Y and Cui W: Homocysteine-related hTERT DNA demethylation contributes to shortened leukocyte telomere length in atherosclerosis. Atherosclerosis 231: 173-179, 2013.
30. Griffiths HR, Aldred S, Dale C, Nakano E, Kitas GD, Grant MG, Nugent D, Taiwo FA, Li L and Powers HJ: Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake. Free Radic Biol Med 40: 488-500, 2006.
31. Hagebeuk EE, Duran M, Abeling NG, Vyth A and Poll-The BT: S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation. J Inherit Metab Dis 36: 967-972, 2013.
32. Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, Shenglan W, Xiaoqun H and Shuren W: Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 26: 603-611, 2007.
33. Yang XL, Tian J, Liang Y, Ma CJ, Yang AN, Wang J, Ma SC, Cheng Y, Hua X and Jiang YD: Homocysteine induces blood vessel global hypomethylation mediated by LOX-1. Genet Mol Res 13: 3787-3799, 2014.
34. Enneman AW, van der Velde N, de Jonge R, Heil SG, Stolk L, Hofman A, Rivadeneira F, Zillikens MC, Uitterlinden AG and van Meurs JB: The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures. Bone 50: 1401-1405, 2012.
35. Maegawa S, Hinkal G, Kim HS, Shen L, Zhang L, Zhang J, Zhang N, Liang S, Donehower LA and Issa JP: Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 20: 332-340, 2010.
36. Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, et al: Fatty acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLoS One 6: e28785, 2011.
37. Orekhov AN, Sobenin IA, Gavrilin MA, Gratchev A, Kotyashova SY, Nikiforov NG and Kzhyshkowska J: Macrophages in immunopathology of atherosclerosis: A target for diagnostics and therapy. Curr Pharm Des 21: 1172-1179, 2015.
38. Shepard CW and Steinberger J: Premature atherosclerotic cardiovascular disease in childhood cancer survivors. Prog Pediatr Cardiol 39: 59-66, 2015.
39. Cash HL, McGarvey ST, Houseman EA, Marsit CJ, Hawley NL, Lambert-Messerlian GM, Viali S, Tuitele J and Kelsey KT: Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics 6: 1257-1264, 2011.
40. Connelly JJ, Cherepanova OA, Doss JF, Karaoli T, Lillard TS, Markunas CA, Nelson S, Wang T, Ellis PD, Langford CF, et al: Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis. Hum Mol Genet 22: 5107-5120, 2013.
41. Terra X, Quintero Y, Auguet T, Porras JA, Hernández M, Sabench F, Aguilar C, Luna AM, Del Castillo D and Richart C: FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 164: 539-547, 2011.
42. Lisanti S, Omar WA, Tomaszewski B, De Prins S, Jacobs G, Koppen G, Mathers JC and Langie SA: Comparison of methods for quantification of global DNA methylation in human cells and tissues. PLoS One 8: e79044, 2013.
43. Girona J, Rosales R, Plana N, Saavedra P, Masana L and Vallvé JC: FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS One 8: e81914, 2013.
44. Yang AN, Zhang HP, Sun Y, Yang XL, Wang N, Zhu G, Zhang H, Xu H, Ma SC, Zhang Y, et al: High-methionine diets accelerate atherosclerosis by HHcy-mediated FABP4 gene demethylation pathway via DNMT1 in ApoE(-/-) mice. FEBS Lett 589: 3998-4009, 2015.
45. Laukkanen MO, Kivelä A, Rissanen T, Rutanen J, Karkkainen MK, Leppanen O, Bräsen JH and Yla-Herttuala S: Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 106: 1999-2003, 2002.
46. Giovannone R, Busetto GM, Antonini G, De Cobelli O, Ferro M, Tricarico S, Del Giudice F, Ragonesi G, Conti SL, Lucarelli G, et al: Hyperhomocysteinemia as an early predictor of erectile dysfunction: International Index of Erectile Function (IIEF) and penile doppler ultrasound correlation with plasma levels of homocysteine. Medicine (Baltimore) 94: e1556, 2015.
47. Kim SJ, Choe YH and Bang OY; Chaos-Biomarker Collaborators: Are stroke biomarkers seeing brain vessels in patients with ischemic stroke?: A C-reactive protein and homocysteine study. Stroke 42: 1464-1468, 2011.
48. Cummings DM, King DE, Mainous AG and Geesey ME: Combining serum biomarkers: The association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur J Cardiovasc Prev Rehabil 13: 180-185, 2006.
49. Liu C, Wang Q, Guo H, Xia M, Yuan Q, Hu Y, Zhu H, Hou M, Ma J, Tang Z and Ling W: Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine. J Nutr 138: 311-315, 2008.
50. Han XB, Zhang HP, Cao CJ, Wang YH, Tian J, Yang XL, Yang AN, Wang J, Jiang YD and Xu H: Aberrant DNA methylation of the PDGF gene in homocysteine-mediated VSMC proliferation and its underlying mechanism. Mol Med Rep 10: 947-954, 2014.
51. Perng W, Villamor E, Shroff MR, Nettleton JA, Pilsner JR, Liu Y and Diez-Roux AV: Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the Multi-Ethnic Study of Atherosclerosis (MESA). Nutr Metab Cardiovasc Dis 24: 614-622, 2014.
52. Zhao J, Forsberg CW, Goldberg J, Smith NL and Vaccarino V: MAOA promoter methylation and susceptibility to carotid atherosclerosis: Role of familial factors in a monozygotic twin sample. BMC Med Genet 13: 100, 2012.
53. Wilson AS, Power BE and Molloy PL: DNA hypomethylation and human diseases. Biochim Biophys Acta 1775: 138-162, 2007.